Information Provided By:
Fly News Breaks for December 19, 2019
NHI
Dec 19, 2019 | 16:42 EDT
Mizuho analyst Omotayo Okusanya assumed coverage of National Health Investors with a Buy rating and $95 price target. The analyst believes National Health is a "misunderstood story" given its origin as a spin off of the skilled nursing assets at National Healthcare Corporation. The company has evolved into a more diversified entity with almost 70% of net operating income from senior housing and just 27% from skilled nursing, Okusanya tells investors in a research note.
News For NHI From the Last 2 Days
There are no results for your query NHI